Navigation Links
When raising capital, why use a Private Placement Memorandum?

Editor's note: Matt Storms is writing a series of articles on raising capital from angel and venture capital investors. This installment focuses on the Private Placement Memorandums, or PPMs, and is co-written with Dan Ghoca.

We are frequently asked whether it is necessary to use a private placement memorandum (also referred to as a PPM or an offering......

Full article >>> ).

If a material misstatement is made, regardless of whether it is intentional, the investors may have a securities fraud claim against the issuer and possibly its officers and directors as well. In addition, the Securities and Exchange Commission can impose civil and criminal penalties, too. A well-prepared PPM helps to avoid a securities fraud claim. It ......

Full article >>> of what we might suggest in many contexts to include in the PPM, although the actual contents of the PPM may vary depending upon the particular offering or circumstances of the company.

Cautionary language: Includes several cautionary statements describing the risks of investing in unregistered securities generally and the offered securities in particular.

Summary of Offering T......

Full article >>> documents that may be material to an investor's investment decision as to whether to invest. The appendices may include copies of the actual investment agreements (instead of just summaries in the PPM itself), detailed financial statements or projections, the organizational documents of the issuer, material agreements or licenses, etc.

Investor-driven content

In summary,......

Full article >>> s on mergers and acquisitions and general corporate law.

The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of the Wisconsin Technology Network, LLC.

WTN accepts no legal liability or responsibility for any claims made or opinions expressed herein.


......

Full article >>>
'"/>

Source:wistechnology.com By Matt Storms 05/20/07


Related biology technology :

1. Capital-raising term sheets for angels and venture capitalists
2. Translating the language of capital-raising
3. Data centers: Blowing smoke and raising red flags
4. Securities compliance is part of raising capital
5. NimbleGen names CFO with capital-raising past
6. The mechanics of raising capital for your business
7. In pursuit of capital, be sure to track your private offering
8. While some bemoan lack of venture capital, entrepreneur touts `bootstrapping for cash
9. Wisconsin places high in nanotech venture capital, average in innovation
10. Entrepreneurs Dont RequireVenture capital, high-tech or government programs
11. TDS Metrocom Rolls Out New Private-line Ethernet Service
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... 2017 Neurotrope, Inc. (OTCQB: NTRP),  a ... diseases, including Alzheimer,s disease, today announced that it ... the Company,s common stock on the NASDAQ Capital ... Market, a unit of the NASDAQ OMX Group. ... Opening Bell at the NASDAQ MarketSite in Times ...
(Date:3/24/2017)... 2017 On Thursday, March 23, ... 5,817.69, down 0.07%; the Dow Jones Industrial Average edged ... 500 closed at 2,345.96, marginally dropping 0.11%. US markets ... green, 4 sectors finished in red, and 1 sector ... initiated reports coverage on the following Biotechnology equities: BioDelivery ...
(Date:3/23/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Global Market for Bioproducts Should ... at a CAGR of 8.9%, This research ... into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ellen Matloff, president and ... Council (CTC) as a 2017 Women of Innovation® finalist. Matloff will be among ... Dinner. , The dinner recognizes women accomplished in science, technology, engineering and math ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/27/2017)... Feb. 27, 2017   Strategic Cyber Ventures , ... has led a $3.5 million investment in  Polarity , ... Cyber Ventures is DC based and is led by ... Thomas . Ron Gula , also a longtime ... participated in this series A round of funding. This ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
Breaking Biology News(10 mins):